Learning Center

Member Exclusive 2021 Webinar: ISCT-ARM-ARMF Webinar: Potential COVID-19 Treatments Using Cell Therapies

  • Register
    • Member - Free!
    • Advanced Practice Professional Member - Free!
    • Complimentary Member - Free!
    • Industry Community - Free!
    • Industry Community Sub Account - Free!
    • Laboratory Member - Free!
    • Laboratory Technologist Sub Account - Free!
    • Laboratory Regular Member Sub Account - Free!
    • Laboratory Resident and Fellow Sub Account - Free!
    • Regular Member - Free!
    • Resident or Fellow Member - Free!
    • Student Member - Free!
    • Technologist Member - Free!

    Continue


April 20, 2021

Webinar Description:

Join leading experts in the cell and gene therapy sector for an expert look at the use of mesenchymal stem cells (MSCs) to treat COVID-19. This 75-minute webinar will cover the science and potential therapeutic benefit of MSCs to treat COVID-19; what patients and patient groups should understand about these therapies; and finally, the ethical and safety concerns for companies and clinics promoting therapies outside of a recognized regulatory process or prior to the conclusion of a clinical trial.


Daniel Weiss, M.D., Ph.D. (Moderator)

Chief Scientific Officer

International Society for Cell & Gene Therapy (ISCT)

Carolyn Hendrickson, M.D., M.P.H.

Assistant Professor

UC San Francisco

Michael Matthay, M.D.

Professor of Medicine

UC San Francisco

Laertis Ikonomou, Ph.D.

Chair, ISCT Presidential Task Force on the Use of Unproven and/or Unethical Cell & Gene Therapy

University at Buffalo

Mike Lehmicke

Director

Alliance for Regenerative Medicine

Patricia Zettler J.D.

Associate Professor of Law

The Ohio State University Moritz College of Law

Key:

Complete
Failed
Available
Locked
ISCT-ARM-ARMF Webinar: Potential COVID-19 Treatments Using Cell Therapies
Open to view video.
Open to view video.
You must register to access.